What does HASHIMOTO do?

HASHIMOTO is a specialist medical practice in Roeselare. Private Limited, started on 24 December 2021, 1 establishment.

What is the address of HASHIMOTO?

The registered office of HASHIMOTO is located at Deltalaan 1, 8800 Roeselare.

Is HASHIMOTO still active?

Yes. According to the CBE (30 October 2026) HASHIMOTO is active, legal situation “Normale toestand”, started on 24 December 2021.

Is HASHIMOTO registered on Peppol?

Yes, HASHIMOTO is registered on the Peppol network with ID 0208:0779364910.

What is the enterprise number of HASHIMOTO?

The enterprise number of HASHIMOTO is BE0779364910.

When was HASHIMOTO founded?

HASHIMOTO was founded on 24 December 2021.

Who are the directors of HASHIMOTO?

According to the 2025 annual accounts, the directors of HASHIMOTO are: PENIJULLINE BV, KASP BV, REIVAX MD BV, DOKTER JAN VAN DEN SAFFELE BV.

Is HASHIMOTO a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 24 December 2021; 4 annual accounts filed, latest fiscal year 2025; 4 directors known from the annual account.

How much profit did HASHIMOTO make in 2025?

HASHIMOTO posted a profit after taxes of € 0 in financial year 2025.

What is the revenue of HASHIMOTO?

As a small company, HASHIMOTO is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 11,867.

HASHIMOTO (Private Limited) - Roeselare - BE0779364910

Dossier HASHIMOTO, printed on 30 October 2026 from databakkes.be/en/0779364910/hashimoto. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Busy address KBO

39 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2025

HASHIMOTO from Roeselare, company number BE0779364910, closed financial year 2025 with a result of € 0 after tax. For that financial year HASHIMOTO recorded a gross margin of € 11,867 and equity of € 10,811. Compared with financial year 2024, the result moved from € 0 to € 0. Around break-even. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 2, 2026.

What it is worth Healthy

€ 10,811

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit

€ 0

Profit after tax over the fiscal year.

Cash in the bank

€ 354,313

▲ 75% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 0.

People and assets in 2025

Wage cost

€ 1,757

▼ 32% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 116,746

▼ 3% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 1,452 Gross margin 2022: € 1,452 First fiscal year in the series	€ 18,871 Gross margin 2023: € 18,871 ▲ € 17,419 vs 2022 (€ 1,452) Favourable step	€ 12,239 Gross margin 2024: € 12,239 ▼ 35% vs 2023 (€ 18,871) Unfavourable step	€ 11,867 Gross margin 2025: € 11,867 ▼ 3% vs 2024 (€ 12,239) Unfavourable step	▼ 3%
Profit after taxes	€ 0 Profit after taxes 2022: € 0 First fiscal year in the series	€ 8,649 Profit after taxes 2023: € 8,649 Unchanged (€ 0) Favourable step	€ 0 Profit after taxes 2024: € 0 ▼ 100% vs 2023 (€ 8,649) Unfavourable step	€ 0 Profit after taxes 2025: € 0 Unchanged (€ 0) Unchanged
Equity	€ 10,811 Equity 2022: € 10,811 First fiscal year in the series	€ 10,811 Equity 2023: € 10,811 Unchanged (€ 10,811) Unchanged	€ 10,811 Equity 2024: € 10,811 Unchanged (€ 10,811) Unchanged	€ 10,811 Equity 2025: € 10,811 Unchanged (€ 10,811) Unchanged
Total debts	€ 1,034,605 Total debts 2022: € 1,034,605 First fiscal year in the series	€ 1,058,384 Total debts 2023: € 1,058,384 ▲ 2% vs 2022 (€ 1,034,605) Unfavourable step	€ 1,116,293 Total debts 2024: € 1,116,293 ▲ 5% vs 2023 (€ 1,058,384) Unfavourable step	€ 1,363,413 Total debts 2025: € 1,363,413 ▲ 22% vs 2024 (€ 1,116,293) Unfavourable step	▲ 22%
Cash	€ 271,336 Cash 2022: € 271,336 First fiscal year in the series	€ 172,180 Cash 2023: € 172,180 ▼ 37% vs 2022 (€ 271,336) Unfavourable step	€ 202,906 Cash 2024: € 202,906 ▲ 18% vs 2023 (€ 172,180) Favourable step	€ 354,313 Cash 2025: € 354,313 ▲ 75% vs 2024 (€ 202,906) Favourable step	▲ 75%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 8,649 Dividend 2023: € 8,649 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 8,649) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 1,045,416 Balance sheet total 2022: € 1,045,416 First fiscal year in the series	€ 1,069,195 Balance sheet total 2023: € 1,069,195 ▲ 2% vs 2022 (€ 1,045,416) Unchanged	€ 1,127,104 Balance sheet total 2024: € 1,127,104 ▲ 5% vs 2023 (€ 1,069,195) Unchanged	€ 1,374,224 Balance sheet total 2025: € 1,374,224 ▲ 22% vs 2024 (€ 1,127,104) Unchanged	▲ 22%

Key figures of HASHIMOTO, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to HASHIMOTO?

What happened at HASHIMOTO in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 2, 2026 New annual accounts for financial year 2025: profit of € 0. Source: NBB ↗
Dec 24, 2021 New establishment in Roeselare. KBO
Dec 24, 2021 Start of the company according to the CBE. KBO

In short

From € 0 profit in 2022 to € 0 profit in 2025.

Paid € 326 in corporate taxes since 2022.

Best year ever: 2023, with € 8,649 profit.

Paid out € 8,649 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

REIVAX MD 25%

PENIJULLINE 25%

The stake of REIVAX MD, PENIJULLINE comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

HASHIMOTO

Behind HASHIMOTO are PENIJULLINE BV, KASP BV, REIVAX MD BV and DOKTER JAN VAN DEN SAFFELE BV. The shares are held by REIVAX MD (25%) and PENIJULLINE (25%).

Directors

According to the 2025 annual accounts

PENIJULLINE BV

Managing director · represented by Francis DUYCK

KASP BV

Managing director · represented by Katrien SPINCEMAILLE

REIVAX MD BV

Director · represented by Xavier-Philippe AERS

DOKTER JAN VAN DEN SAFFELE BV

Director · represented by Jan VAN DEN SAFFELE

Shareholders

REIVAX MD

25%

PENIJULLINE

25%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Deltalaan 1

8800 Roeselare

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 39 companies are registered at this address.

All companies at this address →

Huisartsenwachtpost Alfa

Westwing Cardiologie

Algemeen Ziekenhuis Delta

€ 739.7 million revenue · 2025

ASSOCIATIE UROLOGIE-MIDDEN WEST-VLAANDEREN

CARDIOLOGIE AZ DELTA

€ 15 million revenue · 2025

+34 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0779.364.910

VAT number

BE 0779.364.910

Registered office

Deltalaan 1, 8800 Roeselare

Names & denominations

HASHIMOTO

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

24 December 2021

Peppol

Active · Active since 17 Jul 2026

Activities · NACE

Activiteiten van medisch specialisten

Activiteiten op het gebied van voeding

Overige menselijke gezondheidszorg, n.e.g.

View on CBE Public ↗ Annual accounts (NBB) ↗

HASHIMOTO

Warning lights

Financials

What happened to HASHIMOTO?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions